Dave Rominger

Director Nonclinical Development at Prelude Therapeutics Incorporated - Wilmington, DE, US

Dave Rominger's Colleagues at Prelude Therapeutics Incorporated
Diane Heiser

Executive Director, Translational Medicine

Contact Diane Heiser

Lauren Trull

Associate Director, Clinical Trial Manager

Contact Lauren Trull

Murty Mangena

Senior Director, Technical Operations

Contact Murty Mangena

Joe Rager

Associate Director, Bioanalytical Sciences

Contact Joe Rager

Ganfeng Cao

Senior Director, CMC

Contact Ganfeng Cao

Karl Blom

Senior Director, Discovery Chemistry Analytical

Contact Karl Blom

Caroline Kelley

Senior Human Resources Manager

Contact Caroline Kelley

View All Dave Rominger's Colleagues
Dave Rominger's Contact Details
HQ
302-467-1280
Location
Company
Prelude Therapeutics Incorporated
Dave Rominger's Company Details
Prelude Therapeutics Incorporated logo, Prelude Therapeutics Incorporated contact details

Prelude Therapeutics Incorporated

Wilmington, DE, US • 100 - 249 Employees
BioTech/Drugs

Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Company's lead product candidates are designed to be oral, potent, and selective inhibitors of PRMT5. Prelude's first clinical candidate, PRT543, is in Phase 1 development for advanced solid tumors and select myeloid malignancies. Prelude is also advancing PRT811, a second PRMT5 inhibitor optimized for high brain exposure, in a Phase 1 clinical trial including glioblastoma multiforme. The Company's pipeline also includes its third clinical candidate, PRT1419, an orally available MCL1 inhibitor in Phase 1 development for patients with relapsed/refractory hematologic malignancies, and its two most advanced preclinical candidates, PRT2527, a CDK9 inhibitor, and PRT-SCA2, a SMARCA2 protein degrader.

N/A
Details about Prelude Therapeutics Incorporated
Frequently Asked Questions about Dave Rominger
Dave Rominger currently works for Prelude Therapeutics Incorporated.
Dave Rominger's role at Prelude Therapeutics Incorporated is Director Nonclinical Development.
Dave Rominger's email address is ***@preludetx.com. To view Dave Rominger's full email address, please signup to ConnectPlex.
Dave Rominger works in the Biotechnology industry.
Dave Rominger's colleagues at Prelude Therapeutics Incorporated are Diane Heiser, Lauren Trull, Murty Mangena, Joe Rager, Ganfeng Cao, Karl Blom, Caroline Kelley and others.
Dave Rominger's phone number is 302-467-1280
See more information about Dave Rominger